Protalix Biotherapeutics Inc (PLX)

Operating Cash Flow Growth

-98.74%

Quarterly · Period ending:

PLX logo

PLX Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-98.74%
PLX Quarterly Cash from Operations YoY % (-257.14% → -98.74%)
High-resolution chart · PNG

PLX operating cash flow growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Protalix Biotherapeutics Inc Operating Cash Flow Growth — Quarterly
Period endingOperating Cash Flow Growth
-98.7388%
535.4488%
-49.1356%
-190.9135%
-44.9584%
-220.7736%
11.0153%
159.5964%
-172.592%
239.6931%
237.6867%
25.163%
167.6047%
48.5675%
48.6731%
-389.5745%
-212.8913%
40.7261%
32.6225%
47.8357%
183.1653%
-38.1762%
-104.7735%
-11.7519%
-51.5474%
2.1853%
7.9171%
-123.6454%
35.0829%
22.7026%
-122.7629%
229.4146%
7.5995%
-11.7137%
339.7111%
-206.0993%
26.2829%
12.4571%
-90.2515%
60.2425%
-118.7056%
-49.8988%
20.8658%
9.3004%
17.9936%
23.0096%
-2.7836%
-16.2123%
19.6078%
12.9981%
-360.4064%
-2.3291%
-161.7876%
-52.619%
127.5408%
1.4484%
372.1128%
-57.4975%
17.669%
15.8368%
59.1548%
55.4164%
-113.5847%
-78.8948%
-260.7699%
-49.5319%
2,740.3752%
14.5047%
10.0824%
-57.1316%
41.9948%
-278.3025%
-73.5813%
-35.0479%
21.7271%
-1,587.0191%
-30,499.7373%
-5,167.7804%
-193,139.185%
-364.1874%
62.0059%
-75.3293%
83.3768%
50.4062%
58.5108%
53.9089%
36.6013%
-109.85%
-1.6056%
-34.727%
7.7699%
9.6757%
-21.045%
21.0486%
98.0192%
32.3158%
-105.3941%
27.3432%
-1,077.3513%
29.4179%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.